1. Home
  2. NEXT vs NVAX Comparison

NEXT vs NVAX Comparison

Compare NEXT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$5.29

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
NVAX
Founded
2010
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
NEXT
NVAX
Price
$5.29
$6.68
Analyst Decision
Hold
Hold
Analyst Count
2
8
Target Price
$9.00
$9.75
AVG Volume (30 Days)
3.6M
3.2M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
N/A
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.25
Revenue Growth
N/A
20.27
52 Week Low
$4.99
$5.01
52 Week High
$12.12
$11.55

Technical Indicators

Market Signals
Indicator
NEXT
NVAX
Relative Strength Index (RSI) 38.70 44.03
Support Level $5.31 $6.36
Resistance Level $5.50 $7.00
Average True Range (ATR) 0.23 0.19
MACD 0.00 0.04
Stochastic Oscillator 25.66 50.00

Price Performance

Historical Comparison
NEXT
NVAX

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: